← All organizations
Highest phase reached
Phase 4
First clinical trial
Mar 1, 2003Last known activity
Nov 1, 2024
Timeline
1980s
- Jan 1, 1986
Rijnstate Hospital— Founded
Drugs by trial phase (62 distinct, 39 trials)
Phase 4 (21 own, 0 via acquisition)
Phase 3 (14 own, 0 via acquisition)
Phase 2 (9 own, 0 via acquisition)
Indications
Studied for
- Acquired Immunodeficiency Syndrome
- Acute Coronary Syndrome
- Anemia, Iron-Deficiency
- Angina, Unstable
- Avitaminosis
- Back Pain
- Delirium
- Depression
- Diabetes Mellitus, Type 2
- Epilepsy
- Esophageal Atresia
- Gastroesophageal Reflux
- Hepatitis C
- Hernia
- Hernia, Diaphragmatic
- HIV Infections
- Hyperinsulinism
- Hypogonadism
- Infarction
- Low Back Pain
- Lung Diseases
- Lung Diseases, Obstructive
- Multiple Myeloma
- Multiple Sclerosis
- Myocardial Infarction
- Neoplasms, Plasma Cell
- Non-ST Elevated Myocardial Infarction
- Obesity
- Obesity, Morbid
- Pulmonary Disease, Chronic Obstructive
- Sclerosis
- Syndrome
- Thromboembolism
- Vitamin B 12 Deficiency
- Vitamin D Deficiency
Recent trials (50)
- NCT02819713Lead sponsorN/A—
- NCT02819713Overall official - principal investigatorN/A—
- NCT06614036CollaboratorPhase 4Nov 1, 2024
- NCT06184633Lead sponsorPhase 4May 1, 2024
- NCT06184633Reponsible party - principal investigatorPhase 4May 1, 2024
- NCT06184633Overall official - principal investigatorPhase 4May 1, 2024
- NCT05726240Lead sponsorPhase 2Oct 31, 2023
- NCT06172010CollaboratorPhase 4Apr 1, 2023
- NCT05216328CollaboratorPhase 3Dec 2, 2022
- NCT05508061Overall official - principal investigatorN/AOct 19, 2022
- NCT05581420CollaboratorN/AJun 2, 2022
- NCT05142904Lead sponsorPhase 3Nov 17, 2021
- NCT04481256CollaboratorN/AOct 1, 2020
- NCT04420455Lead sponsorPhase 4Jul 31, 2020
- NCT04673461Overall official - principal investigatorPhase 2Jul 31, 2020
Details
- Founded
- Arnhem, NL Jan 1, 1986
- Last known activity
- Nov 1, 2024